Molecular Partners Ag (MOLN) Current Assets (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Current Assets for 7 consecutive years, with $90.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets fell 37.94% year-over-year to $90.4 million in Q2 2026; TTM through Jun 2026 was $90.4 million, a 37.94% decrease from a year earlier, with the FY2025 full-year figure at $116.8 million, down 33.37% from the prior year.
• Current Assets was $90.4 million for Q2 2026 at Molecular Partners Ag, down from $105.9 million in the prior quarter.
• Over five years, Current Assets peaked at $328.7 million in Q1 2022 and troughed at $90.4 million in Q2 2026.
• A 5-year average of $201.8 million and a median of $194.8 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets surged 55.2% in 2022 and sank 37.94% in 2026, its largest moves.
• Over 5 years, Current Assets stood at $264.4 million in 2022, then decreased by 17.95% to $217.0 million in 2023, then fell by 18.83% to $176.1 million in 2024, then tumbled by 31.18% to $121.2 million in 2025, then decreased by 25.44% to $90.4 million in 2026.
• The last three Current Assets figures came in at $90.4 million (Q2 2026), $105.9 million (Q1 2026), and $121.2 million (Q4 2025), per Business Quant data.